Literature DB >> 29221308

How to manage tumor located between upper division and lingular segment "S3+S4 segmentectomy and S3b+S4 segmentectomy".

Shin-Ichi Yamashita1, Yasuhiro Yoshida1, Daisuke Hamatake1, Takeshi Shiraishi1, Katsunobu Kawahara2, Akinori Iwasaki1.   

Abstract

Segmentectomy is one of the treatment of choice for small-sized non-small cell lung cancer (NSCLC). Although simple segmentectomy is feasible even if under thoracoscopy, complicated segmentectomy which contains more than two segmental plane divisions is difficult especially thoracoscopic surgery. We here present the case of totally thoracoscopic segmentectomy between upper division and lingular segment. In the first case, the 64-year-old female patient admitted for further examination and treatment of left lung ground glass nodule. Tumor located between upper division (S3) and lingular (S4) segment was operated by bi-segmentectomy and intraoperative frozen section pathology showed minimally invasive adenocarcinoma. Systematic nodal dissection was followed after retrieval of specimens. A3b A3a+c, and A4 was individually divided and followed by division of B3 and B4. Finally, intersegmental veins V1+2a and V1+2d was identified between segments and V3a+b was divided. In the second case, the 76-year-old female patient with left lung nodule between upper division (S3b) and lingular (S4) segment was operated by bi-segmentectomy. Since sealing test revealed air leakage from resected segmental planes, fibrin glue was applied to stop air leakage and direct suturing by 4-0 prolene between S3a+S3c and S5 was performed. Target lesion between upper division and lingular segments may be resected safely if appropriate demarcation lines are identified regardless of without highly sophisticated imaging systems.

Entities:  

Keywords:  Lung cancer; S3 and S4; middle segment; segmentectomy

Year:  2017        PMID: 29221308      PMCID: PMC5708462          DOI: 10.21037/jtd.2017.07.63

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  5 in total

Review 1.  Video-assisted thoracic surgery for lung cancer: republication of a systematic review and a proposal by the guidelines committee of the Japanese Association for Chest Surgery 2014.

Authors:  Shin-Ichi Yamashita; Taichiro Goto; Takeshi Mori; Hirotoshi Horio; Yoshihisa Kadota; Takeshi Nagayasu; Akinori Iwasaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-09-03

2.  Thoracoscopic segmentectomy for T1 classification of non-small cell lung cancer: a single center experience.

Authors:  Shin-ichi Yamashita; Keita Tokuishi; Kentaro Anami; Toshihiko Moroga; Michiyo Miyawaki; Masao Chujo; Satoshi Yamamoto; Katsunobu Kawahara
Journal:  Eur J Cardiothorac Surg       Date:  2012-01-06       Impact factor: 4.191

3.  Video-assisted thoracoscopic surgery segmentectomy: a safe and effective procedure.

Authors:  Bradley G Leshnower; Daniel L Miller; Felix G Fernandez; Allan Pickens; Seth D Force
Journal:  Ann Thorac Surg       Date:  2010-05       Impact factor: 4.330

4.  Feasibility of video-assisted thoracoscopic surgery segmentectomy for selected peripheral lung carcinomas.

Authors:  Atsushi Watanabe; Syunsuke Ohori; Shinji Nakashima; Tohru Mawatari; Norio Inoue; Yoshihikoi Kurimoto; Tetsuya Higami
Journal:  Eur J Cardiothorac Surg       Date:  2009-02-23       Impact factor: 4.191

5.  Quality of life following lung cancer resection: video-assisted thoracic surgery vs thoracotomy.

Authors:  Wilson W L Li; T W Lee; Shirley S Y Lam; Calvin S H Ng; Alan D L Sihoe; Innes Y P Wan; Anthony P C Yim
Journal:  Chest       Date:  2002-08       Impact factor: 9.410

  5 in total
  2 in total

1.  Safe resection margin in video-assisted left anterior and lingular segmentectomy for an impalpable lung nodule.

Authors:  Kotaro Mizuno; Tadashi Sakane
Journal:  Int J Surg Case Rep       Date:  2019-05-07

2.  Uniportal video-assisted thoracoscopic left S4 anatomical segmentectomy.

Authors:  Nan Song; Liang Duan; Zhiyong Fang; Gening Jiang
Journal:  Thorac Cancer       Date:  2019-02-13       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.